These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38488949)

  • 1. The impact of exercise on blood-based biomarkers of Alzheimer's disease in cognitively unimpaired older adults.
    Sewell KR; Rainey-Smith SR; Pedrini S; Peiffer JJ; Sohrabi HR; Taddei K; Markovic SJ; Martins RN; Brown BM
    Geroscience; 2024 Dec; 46(6):5911-5923. PubMed ID: 38488949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood biomarkers of neurodegeneration associate differently with amyloid deposition, medial temporal atrophy, and cerebrovascular changes in APOE ε4-enriched cognitively unimpaired elderly.
    Koivumäki M; Ekblad L; Lantero-Rodriguez J; Ashton NJ; Karikari TK; Helin S; Parkkola R; Lötjönen J; Zetterberg H; Blennow K; Rinne JO; Snellman A
    Alzheimers Res Ther; 2024 May; 16(1):112. PubMed ID: 38762725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stage-specific links between plasma neurofilament light and imaging biomarkers of Alzheimer's disease.
    Benedet AL; Leuzy A; Pascoal TA; Ashton NJ; Mathotaarachchi S; Savard M; Therriault J; Kang MS; Chamoun M; Schöll M; Zimmer ER; Gauthier S; Labbe A; Zetterberg H; Rosa-Neto P; Blennow K;
    Brain; 2020 Dec; 143(12):3793-3804. PubMed ID: 33210117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astrocyte reactivity is associated with tau tangle load and cortical thinning in Alzheimer's disease.
    Guo T; Li A; Sun P; He Z; Cai Y; Lan G; Liu L; Li J; Yang J; Zhu Y; Zhao R; Chen X; Shi D; Liu Z; Wang Q; Xu L; Zhou L; Ran P; Wang X; Sun K; Lu J; Han Y
    Mol Neurodegener; 2024 Jul; 19(1):58. PubMed ID: 39080744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies.
    Bolsewig K; van Unnik AAJM; Blujdea ER; Gonzalez MC; Ashton NJ; Aarsland D; Zetterberg H; Padovani A; Bonanni L; Mollenhauer B; Schade S; Vandenberghe R; Poesen K; Kramberger MG; Paquet C; Bousiges O; Cretin B; Willemse EAJ; Teunissen CE; Lemstra AW;
    Neurology; 2024 Jun; 102(12):e209418. PubMed ID: 38830138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Longitudinal Cognitive Decline and Alzheimer's Conversion in Mild Cognitive Impairment Patients Based on Plasma Biomarkers.
    Park MK; Ahn J; Kim YJ; Lee JW; Lee JC; Hwang SJ; Kim KC
    Cells; 2024 Jun; 13(13):. PubMed ID: 38994939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma Aβ42/40 ratio, p-tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross-sectional and longitudinal study in the AIBL cohort.
    Chatterjee P; Pedrini S; Doecke JD; Thota R; Villemagne VL; Doré V; Singh AK; Wang P; Rainey-Smith S; Fowler C; Taddei K; Sohrabi HR; Molloy MP; Ames D; Maruff P; Rowe CC; Masters CL; Martins RN;
    Alzheimers Dement; 2023 Apr; 19(4):1117-1134. PubMed ID: 36574591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
    Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
    Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of plasma biomarkers of Alzheimer's disease and related disorders with cognition and cognitive decline: The MYHAT population-based study.
    Zhang Y; Ferreira PCL; Jacobsen E; Bellaver B; Pascoal TA; Snitz BE; Chang CH; Villemagne VL; Ganguli M; Karikari TK
    Alzheimers Dement; 2024 Jun; 20(6):4199-4211. PubMed ID: 38753951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Alzheimer Disease Blood Biomarkers and Associations With Incident All-Cause Dementia.
    Lu Y; Pike JR; Chen J; Walker KA; Sullivan KJ; Thyagarajan B; Mielke MM; Lutsey PL; Knopman D; Gottesman RF; Sharrett AR; Coresh J; Mosley TH; Palta P
    JAMA; 2024 Oct; 332(15):1258-1269. PubMed ID: 39068543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma markers of neurodegeneration, latent cognitive abilities and physical activity in healthy aging.
    Nilsson J; Jiang Y; Johannesson M; Moberg M; Wang R; Fabre S; Lövdén M; Ekblom Ö; Ekblom M
    Sci Rep; 2024 Sep; 14(1):21702. PubMed ID: 39289522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Plasma Biomarkers for A/T/N Classification of Alzheimer Disease Among Adults of Caribbean Hispanic Ethnicity.
    Honig LS; Kang MS; Lee AJ; Reyes-Dumeyer D; Piriz A; Soriano B; Franco Y; Coronado ZD; Recio P; Mejía DR; Medrano M; Lantigua RA; Teich AF; Dage JL; Mayeux R
    JAMA Netw Open; 2023 Apr; 6(4):e238214. PubMed ID: 37079306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic and prognostic plasma biomarkers for preclinical Alzheimer's disease.
    Chatterjee P; Pedrini S; Ashton NJ; Tegg M; Goozee K; Singh AK; Karikari TK; Simrén J; Vanmechelen E; Armstrong NJ; Hone E; Asih PR; Taddei K; Doré V; Villemagne VL; Sohrabi HR; Zetterberg H; Masters CL; Blennow K; Martins RN
    Alzheimers Dement; 2022 Jun; 18(6):1141-1154. PubMed ID: 34494715
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma neurofilament light, glial fibrillary acid protein, and phosphorylated tau 181 as biomarkers for neuropsychiatric symptoms and related clinical disease progression.
    Rabl M; Zullo L; Lewczuk P; Kornhuber J; Karikari TK; Blennow K; Zetterberg H; Bavato F; Quednow BB; Seifritz E; von Gunten A; Clark C; Popp J
    Alzheimers Res Ther; 2024 Jul; 16(1):165. PubMed ID: 39054505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathologic and cognitive correlates of plasma biomarkers in neurodegenerative disease.
    Cousins KAQ; Phillips JS; Das SR; O'Brien K; Tropea TF; Chen-Plotkin A; Shaw LM; Nasrallah IM; Mechanic-Hamilton D; McMillan CT; Irwin DJ; Lee EB; Wolk DA
    Alzheimers Dement; 2024 Jun; 20(6):3889-3905. PubMed ID: 38644682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma GFAP, NfL and pTau 181 detect preclinical stages of dementia.
    Ingannato A; Bagnoli S; Mazzeo S; Giacomucci G; Bessi V; Ferrari C; Sorbi S; Nacmias B
    Front Endocrinol (Lausanne); 2024; 15():1375302. PubMed ID: 38654932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurodegenerative biomarkers in different chambers of the eye relative to plasma: an agreement validation study.
    Sampani K; Ness S; Tuz-Zahra F; Aytan N; Spurlock EE; Alluri S; Chen X; Siegel NH; Alosco ML; Xia W; Tripodis Y; Stein TD; Subramanian ML
    Alzheimers Res Ther; 2024 Aug; 16(1):192. PubMed ID: 39187891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Central autonomic network dysfunction and plasma Alzheimer's disease biomarkers in older adults.
    Lohman T; Kapoor A; Engstrom AC; Shenasa F; Alitin JPM; Gaubert A; Rodgers KE; Bradford D; Mather M; Han SD; Head E; Sordo L; Thayer JF; Nation DA
    Alzheimers Res Ther; 2024 Jun; 16(1):124. PubMed ID: 38851772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of plasma and neuroimaging biomarkers to predict cognitive decline in non-demented memory clinic patients.
    Mendes AJ; Ribaldi F; Lathuiliere A; Ashton NJ; Zetterberg H; Abramowicz M; Scheffler M; Assal F; Garibotto V; Blennow K; Frisoni GB
    Alzheimers Res Ther; 2024 May; 16(1):110. PubMed ID: 38755703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.